- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||tabalumab|
|Search PubMed titles||tabalumab|
|Search PubMed titles/abstracts||tabalumab|
|Tabalumab is a monoclonal antibody directed against B-cell activating factor (BAFF, TNFSF13B). It was being developed as a treatment for autoimmune diseases  and B cell malignancies.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. Peptide sequence BLAST search using the heavy chain variable region of tabalumab provides 100% match to a sequence covered by patent US7317089 , and to the antibody with designation 4A5-3.1.1-B4.